Press Releases Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
0.95 ^USD	+0.07%		+25.16%	-49.74%

17/04	Bionano Genomics, Hangzhou Diagens Biotechnology to Commercialize Cytogenetic Workflow for Reproductive Health	MT
17/04	Bionano Genomics, Inc. and Hangzhou Diagens Biotechnology Co., Ltd. Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines OGM and Artificial Intelligence	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024	01/05	AQ
Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference	01/05	AQ
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	25/04	AQ
Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing	24/04	AQ
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence	17/04	AQ
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing	11/04	AQ
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	04/04	AQ
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics	03/04	AQ
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting	02/04	AQ
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance	19/03	AQ
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System	07/03	AQ
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024	06/03	AQ
Bionano to Present at TD Cowen’s 44th Annual Health Care Conference	29/02	AQ
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024	28/02	AQ
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway	28/02	AQ
American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis	22/02	AQ
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference	31/01	AQ
Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS	30/01	AQ
Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer	25/01	AQ
Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing	24/01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Press Releases

Filters